White Pine Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,625
| Closed | -$204K | – | 210 |
|
|
2023
Q1 | $204K | Hold |
5,625
| – | – | 0.08% | 195 |
|
|
2022
Q4 | $201K | Buy |
+5,625
| New | +$201K | 0.08% | 190 |
|
|
2020
Q3 | – | Sell |
-8,875
| Closed | -$211K | – | 217 |
|
|
2020
Q2 | $211K | Sell |
8,875
-1,675
| -16% | -$39.8K | 0.09% | 191 |
|
|
2020
Q1 | $190K | Hold |
10,550
| – | – | 0.1% | 182 |
|
|
2019
Q4 | $250K | Sell |
10,550
-7,000
| -40% | -$166K | 0.1% | 193 |
|
|
2019
Q3 | $482K | Sell |
17,550
-3,360
| -16% | -$92.3K | 0.18% | 142 |
|
|
2019
Q2 | $692K | Sell |
20,910
-625
| -3% | -$20.7K | 0.26% | 117 |
|
|
2019
Q1 | $755K | Sell |
21,535
-6,950
| -24% | -$244K | 0.28% | 113 |
|
|
2018
Q4 | $946K | Buy |
28,485
+3,060
| +12% | +$102K | 0.39% | 74 |
|
|
2018
Q3 | $1.28M | Hold |
25,425
| – | – | 0.45% | 65 |
|
|
2018
Q2 | $1.52M | Sell |
25,425
-450
| -2% | -$26.9K | 0.54% | 52 |
|
|
2018
Q1 | $1.19M | Sell |
25,875
-650
| -2% | -$29.8K | 0.44% | 61 |
|
|
2017
Q4 | $1.06M | Sell |
26,525
-1,640
| -6% | -$65.4K | 0.39% | 71 |
|
|
2017
Q3 | $1.13K | Sell |
28,165
-710
| -2% | -$28 | ﹤0.01% | 73 |
|
|
2017
Q2 | $1.25M | Sell |
28,875
-225
| -0.8% | -$9.7K | 0.49% | 52 |
|
|
2017
Q1 | $911K | Buy |
29,100
+150
| +0.5% | +$4.7K | 0.37% | 81 |
|
|
2016
Q4 | $731K | Buy |
28,950
+1,200
| +4% | +$30.3K | 0.31% | 95 |
|
|
2016
Q3 | $686K | Sell |
27,750
-15,350
| -36% | -$379K | 0.29% | 94 |
|
|
2016
Q2 | $878K | Buy |
43,100
+14,825
| +52% | +$302K | 0.37% | 74 |
|
|
2016
Q1 | $431K | Buy |
+28,275
| New | +$431K | 0.18% | 149 |
|